Saturday 17 October 2026
Export ATRC’s income statement to Excel — free account
AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
56.09
1.69
−2.92%
Follow ATRC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 62.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
7 | 4 | 6 | 3 | 4 | 4 | 2 | 5 | 4 | 4 |
P/S ratio |
3.53 | 3.08 | 4.10 | 6.21 | 11.42 | 11.35 | 5.29 | 5.17 | 3.42 | 3.91 |
Altman Z-Score |
7.31 | 5.81 | 6.78 | 9.33 | 14.67 | 4.53 | 2.07 | 5.72 | 2.72 | 2.87 |
P/FCF ratio |
103.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
3.44 | 2.76 | 3.17 | 3.18 | 4.47 | 1.87 | (0.12) | 2.33 | (0.56) | (0.12) |
Beneish M-Score |
(2.91) | (2.80) | (2.60) | (2.24) | (1.75) | (2.85) | (2.28) | (2.70) | (2.73) | (2.88) |
P/Operating CF |
94.32 | 245.93 | 405.86 | 44,586.56 | 10,410.10 | 593.10 | (346.28) | 1,058.95 | 391.48 | 797.49 |
P/B ratio |
3.84 | 3.11 | 3.51 | 4.49 | 6.48 | 5.69 | 4.94 | 4.18 | 3.71 | 3.60 |
Price to Tangible BV |
9.03 | 8.46 | 9.77 | 11.23 | 15.21 | 47.46 | 0.00 | 10.99 | 116.27 | 54.90 |
EV/Sales |
3.40 | 3.00 | 3.96 | 6.06 | 11.25 | 10.49 | 5.26 | 4.81 | 3.45 | 3.89 |
EV/EBITDA |
157.03 | 0.00 | 0.00 | 0.00 | 20.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
31.67 | 114.31 | 352.28 | (90.39) | (223.94) | (109.07) | (76.77) | (232.30) | (67.43) | (39.86) |
EV/FCF |
99.30 | (47.73) | (42.11) | (51.29) | (131.13) | (86.24) | (43.42) | (93.38) | (39.35) | (26.42) |
Quick Ratio |
2.87 | 2.49 | 2.55 | 2.81 | 2.69 | 5.44 | 2.20 | 3.72 | 1.80 | 2.26 |
Current Ratio |
3.96 | 3.65 | 3.57 | 3.69 | 3.47 | 6.24 | 2.87 | 4.34 | 2.58 | 2.97 |
Net Debt/EBITDA |
(9.13) | 2.94 | 7.13 | 1.71 | (0.31) | 5.41 | 0.34 | 8.75 | (0.19) | 0.24 |
Debt/Assets |
9.46% | 10.15% | 9.87% | 12.20% | 11.63% | 9.26% | 13.20% | 14.70% | 13.98% | 14.07% |
Debt/Equity |
0.13 | 0.13 | 0.13 | 0.16 | 0.15 | 0.16 | 0.30 | 0.21 | 0.23 | 0.23 |
Asset Turnover |
0.85 | 0.76 | 0.67 | 0.55 | 0.41 | 0.32 | 0.50 | 0.65 | 0.64 | 0.56 |
Operating CF/Net income |
(5.01) | (0.27) | (0.15) | 0.48 | (0.27) | 0.41 | 0.45 | 0.20 | 0.33 | 0.45 |
Capex/Depreciation |
(0.43) | (0.59) | (0.75) | (1.23) | (0.10) | (0.47) | (1.38) | (0.70) | (0.68) | (0.80) |
Interest Coverage |
(1.61) | (6.25) | (3.85) | (8.56) | 11.23 | (9.05) | (8.06) | (3.72) | (11.03) | (17.29) |
| (2.40%) | (9.64%) | (6.60%) | (9.88%) | 11.20% | (14.60%) | (14.17%) | (10.30%) | (16.32%) | (18.78%) | |
| (1.81%) | (7.31%) | (5.08%) | (7.74%) | 7.55% | (7.57%) | (7.70%) | (6.77%) | (9.88%) | (12.13%) | |
ROIC |
(1.53%) | (6.25%) | (4.28%) | (6.55%) | 7.91% | (11.80%) | (8.66%) | (6.03%) | (9.51%) | (11.92%) |
Return on Tangible Assets |
(4.09%) | (18.93%) | (13.00%) | (23.75%) | 29.35% | (16.84%) | (27.96%) | (13.08%) | (34.00%) | (38.37%) |
Average Days of Receivables |
45.51 | 47.33 | 48.00 | 47.17 | 43.94 | 40.91 | 44.35 | 45.61 | 48.22 | 49.64 |
Research and Development Expense of Revenue |
18.56% | 20.67% | 18.51% | 17.35% | 17.68% | 20.85% | 17.86% | 17.22% | 19.54% | 23.10% |
Selling, General and Administrative Expense of Revenue |
58.19% | 62.62% | 63.40% | 70.00% | 74.60% | 73.03% | 72.42% | 64.24% | 66.96% | 68.61% |
Intangible Assets out of Total Assets |
0.43 | 0.48 | 0.49 | 0.47 | 0.45 | 0.51 | 0.65 | 0.43 | 0.58 | 0.57 |
Share Based Compensation of Revenue |
8.36% | 8.68% | 8.95% | 8.71% | 10.24% | 10.96% | 7.79% | 8.18% | 8.37% | 7.54% |
Graham Net Nets |
0.08 | 0.08 | 0.07 | 0.04 | 0.02 | 0.00 | (0.14) | 0.06 | (0.04) | (0.04) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 16.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.60%) | (3.11%) | (1.87%) | (2.25%) | 1.60% | (2.07%) | (2.86%) | (2.06%) | (4.49%) | (5.47%) |
Free Cash Flow Yield |
0.97% | (2.04%) | (2.29%) | (1.90%) | (0.75%) | (1.07%) | (2.29%) | (0.99%) | (2.56%) | (3.76%) |
Revenue per Share |
11.19 | 9.91 | 8.62 | 7.22 | 6.09 | 4.90 | 6.14 | 5.92 | 5.39 | 4.91 |
Operating CF per Share |
1.20 | 0.26 | 0.10 | (0.48) | (0.31) | (0.47) | (0.42) | (0.12) | (0.28) | (0.48) |
Capex per Share |
(0.19) | (0.24) | (0.26) | (0.37) | (0.22) | (0.12) | (0.32) | (0.18) | (0.20) | (0.24) |
Free Cash Flow per Share |
1.01 | 0.02 | (0.16) | (0.85) | (0.52) | (0.60) | (0.74) | (0.30) | (0.47) | (0.72) |
Cash per Share |
3.51 | 2.61 | 2.96 | 2.65 | 2.64 | 5.80 | 2.18 | 3.65 | 1.06 | 1.39 |
Shareholders Equity per Share |
10.30 | 9.82 | 10.07 | 9.99 | 10.73 | 9.79 | 6.58 | 7.32 | 4.98 | 5.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.30 | 9.82 | 10.07 | 9.99 | 10.73 | 9.79 | 6.58 | 7.32 | 4.98 | 5.33 |
Free Cash Flow |
48.28 | 0.77 | (7.51) | (39.02) | (23.53) | (25.13) | (27.95) | (10.38) | (15.33) | (22.81) |
Working Capital |
241.00 | 194.40 | 191.68 | 156.82 | 139.63 | 257.60 | 93.24 | 134.46 | 50.36 | 56.89 |
Capital Expenditures |
(9.05) | (11.43) | (12.00) | (16.88) | (9.75) | (5.26) | (12.14) | (6.20) | (6.38) | (7.69) |
Net Current Asset Value |
160.27 | 119.47 | 118.48 | 86.52 | 64.52 | 4.59 | (167.38) | 67.30 | (24.28) | (22.26) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 55.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.05 | 0.04 | 0.03 | 0.05 | 0.03 | 0.04 | 0.05 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 56.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.54 | 0.46 | 0.38 | 0.35 | 3.06 | 0.40 | 0.27 | 0.33 | 0.33 | 0.32 |
Cash ROIC |
6.69% | 0.12% | (1.13%) | (6.01%) | (3.49%) | (3.48%) | (6.94%) | (2.43%) | (6.58%) | (9.07%) |
Accounts Receivable Turnover |
8.42 | 8.25 | 8.39 | 8.73 | 9.77 | 8.07 | 8.67 | 8.35 | 7.91 | 7.66 |
Accounts Payable Turnover |
5.31 | 4.50 | 4.19 | 4.39 | 4.37 | 4.13 | 4.92 | 4.94 | 4.20 | 3.76 |
Inventory Turnover |
1.74 | 1.64 | 1.74 | 1.99 | 1.85 | 1.78 | 2.33 | 2.43 | 2.42 | 2.49 |
Average Days of Payables |
69.07 | 77.57 | 100.98 | 86.01 | 99.14 | 81.24 | 90.22 | 64.68 | 93.45 | 88.52 |
Days of Inventory on Hand |
214.20 | 233.46 | 250.64 | 198.54 | 207.71 | 223.42 | 177.54 | 150.55 | 168.78 | 146.47 |
Average Receivables |
63.50 | 56.42 | 47.60 | 37.86 | 28.08 | 25.60 | 26.62 | 24.14 | 22.09 | 20.25 |
Average Payables |
25.17 | 26.19 | 23.63 | 19.25 | 15.67 | 13.84 | 12.30 | 11.05 | 11.55 | 11.71 |
Average Inventory |
76.91 | 71.62 | 56.91 | 42.45 | 37.00 | 32.22 | 25.95 | 22.47 | 20.06 | 17.66 |
Average Assets |
631.75 | 611.63 | 599.69 | 600.38 | 664.93 | 636.21 | 457.32 | 312.23 | 272.06 | 274.76 |
Average Common Equity |
476.45 | 463.57 | 461.46 | 470.26 | 448.08 | 329.87 | 248.36 | 205.27 | 164.80 | 177.56 |
Columns are period end dates